The glomerular basement membrane

Experimental Cell Research

Volumn 318, Issue 9, 2012, Pages 973-978

  Miner, Jeffrey H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alport syndrome; Collagen IV; Laminin; Pierson syndrome

Indexed keywords

AGRIN; COLLAGEN TYPE 4; ENTACTIN; ENTACTIN 1; ENTACTIN 2; EPIDERMAL GROWTH FACTOR; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; LAMININ; LAMININ ALPHA5; LAMININ BETA1; LAMININ BETA2; MESSENGER RNA; PERLECAN; UNCLASSIFIED DRUG;

ALPORT SYNDROME; ANEURYSM; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONGENITAL NEPHROTIC SYNDROME; DISEASE SEVERITY; ENZYME ACTIVITY; GENE MUTATION; GLOMERULAR FILTRATION BARRIER; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; HUMAN; HYDRONEPHROSIS; KIDNEY DISEASE; KIDNEY DYSFUNCTION; MOUSE MUTANT; MUSCLE CRAMP; NEPHRITIS; NEUROMUSCULAR SYNAPSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASCULAR DISEASE; VASCULARIZATION; ZYGOSITY;

MUS;

EID: 84859814741     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.02.031     Document Type: Review

References (43)

1. Haraldsson B., Jeansson M. Glomerular filtration barrier. Curr. Opin. Nephrol. Hypertens. 2009, 18:331-335.
2. Simons M., Huber T.B. It's not all about nephrin. Kidney Int. 2008, 73:671-673.
3. Farquhar M.G. Editorial: The primary glomerular filtration barrier-basement membrane or epithelial slits?. Kidney Int. 1975, 8:197-211.
4. Maynard S.E., Karumanchi S.A. Angiogenic factors and preeclampsia. Semin. Nephrol. 2011, 31:33-46.
5. Timpl R. Structure and biological activity of basement membrane proteins. Eur. J. Biochem. 1989, 180:487-502.
6. Aumailley M., Bruckner-Tuderman L., Carter W.G., Deutzmann R., Edgar D., Ekblom P., Engel J., Engvall E., Hohenester E., Jones J.C., Kleinman H.K., Marinkovich M.P., Martin G.R., Mayer U., Meneguzzi G., Miner J.H., Miyazaki K., Patarroyo M., Paulsson M., Quaranta V., Sanes J.R., Sasaki T., Sekiguchi K., Sorokin L.M., Talts J.F., Tryggvason K., Uitto J., Virtanen I., von der Mark K., Wewer U.M., Yamada Y., Yurchenco P.D. A simplified laminin nomenclature. Matrix Biol. 2005, 24:326-332.
7. Sztal T., Berger S., Currie P.D., Hall T.E. Characterization of the laminin gene family and evolution in zebrafish. Dev. Dyn. 2011, 240:422-431.
8. McKee K.K., Harrison D., Capizzi S., Yurchenco P.D. Role of laminin terminal globular domains in basement membrane assembly. J. Biol. Chem. 2007, 282:21437-21447.
9. Miner J.H. Developmental biology of glomerular basement membrane components. Curr. Opin. Nephrol. Hypertens. 1998, 7:13-19.
10. Miner J.H., Patton B.L., Lentz S.I., Gilbert D.J., Snider W.D., Jenkins N.A., Copeland N.G., Sanes J.R. The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform. J. Cell Biol. 1997, 137:685-701.
11. Miner J.H., Sanes J.R. Collagen IV α3, α4, and α5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches. J. Cell Biol. 1994, 127:879-891.
12. Miner J.H., Li C. Defective glomerulogenesis in the absence of laminin α5 demonstrates a developmental role for the kidney glomerular basement membrane. Dev. Biol. 2000, 217:278-289.
13. Smyth N., Vatansever H.S., Murray P., Meyer M., Frie C., Paulsson M., Edgar D. Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation. J. Cell Biol. 1999, 144:151-160.
14. Shannon M.B., Patton B.L., Harvey S.J., Miner J.H. A hypomorphic mutation in the mouse laminin alpha5 gene (Lama5) causes polycystic kidney disease. J. Am. Soc. Nephrol. 2006, 17:1913-1922.
15. Matejas V., Hinkes B., Alkandari F., Al-Gazali L., Annexstad E., Aytac M.B., Barrow M., Blahova K., Bockenhauer D., Cheong H.I., Maruniak-Chudek I., Cochat P., Dotsch J., Gajjar P., Hennekam R.C., Janssen F., Kagan M., Kariminejad A., Kemper M.J., Koenig J., Kogan J., Kroes H.Y., Kuwertz-Broking E., Lewanda A.F., Medeira A., Muscheites J., Niaudet P., Pierson M., Saggar A., Seaver L., Suri M., Tsygin A., Wuhl E., Zurowska A., Uebe S., Hildebrandt F., Antignac C., Zenker M. Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum. Hum. Mutat. 2010, 31:992-1002.
16. Noakes P.G., Miner J.H., Gautam M., Cunningham J.M., Sanes J.R., Merlie J.P. The renal glomerulus of mice lacking s-laminin/laminin beta2: nephrosis despite molecular compensation by laminin beta1. Nat. Genet. 1995, 10:400-406.
17. Jarad G., Cunningham J., Shaw A.S., Miner J.H. Proteinuria precedes podocyte abnormalities in Lamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier. J. Clin. Invest. 2006, 116:2272-2279.
18. Suh J.H., Jarad G., Vandevoorde R.G., Miner J.H. Forced expression of laminin {beta}1 in podocytes prevents nephrotic syndrome in mice lacking laminin {beta}2, a model for Pierson syndrome. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:15348-15353.
19. Poschl E., Schlotzer-Schrehardt U., Brachvogel B., Saito K., Ninomiya Y., Mayer U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 2004, 131:1619-1628.
20. Abrahamson D.R., Hudson B.G., Stroganova L., Borza D.B., St John P.L. Cellular origins of type IV collagen networks in developing glomeruli. J. Am. Soc. Nephrol. 2009, 20:1471-1479.
21. Plaisier E., Gribouval O., Alamowitch S., Mougenot B., Prost C., Verpont M.C., Marro B., Desmettre T., Cohen S.Y., Roullet E., Dracon M., Fardeau M., Van Agtmael T., Kerjaschki D., Antignac C., Ronco P. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N. Engl. J. Med. 2007, 357:2687-2695.
22. Plaisier E., Chen Z., Gekeler F., Benhassine S., Dahan K., Marro B., Alamowitch S., Paques M., Ronco P. Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain. Am. J. Med. Genet. A 2010, 152A:2550-2555.
23. Eble J.A., Golbik R., Mann K., Kuhn K. The alpha 1 beta 1 integrin recognition site of the basement membrane collagen molecule [alpha 1(IV)]2 alpha 2(IV). EMBO J. 1993, 12:4795-4802.
24. Gould D.B., Phalan F.C., Breedveld G.J., van Mil S.E., Smith R.S., Schimenti J.C., Aguglia U., van der Knaap M.S., Heutink P., John S.W. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science 2005, 308:1167-1171.
25. Gould D.B., Phalan F.C., van Mil S.E., Sundberg J.P., Vahedi K., Massin P., Bousser M.G., Heutink P., Miner J.H., Tournier-Lasserve E., John S.W. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N. Engl. J. Med. 2006, 354:1489-1496.
26. Van Agtmael T., Schlotzer-Schrehardt U., McKie L., Brownstein D.G., Lee A.W., Cross S.H., Sado Y., Mullins J.J., Poschl E., Jackson I.J. Dominant mutations of Col4a1 result in basement membrane defects which lead to anterior segment dysgenesis and glomerulopathy. Hum. Mol. Genet. 2005, 14:3161-3168.
27. Fox J.W., Mayer U., Nischt R., Aumailley M., Reinhardt D., Wiedemann H., Mann K., Timpl R., Krieg T., Engel J. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J. 1991, 10:3137-3146.
28. Murshed M., Smyth N., Miosge N., Karolat J., Krieg T., Paulsson M., Nischt R. The absence of nidogen 1 does not affect murine basement membrane formation. Mol. Cell. Biol. 2000, 20:7007-7012.
29. Schymeinsky J., Nedbal S., Miosge N., Poschl E., Rao C., Beier D.R., Skarnes W.C., Timpl R., Bader B.L. Gene structure and functional analysis of the mouse nidogen-2 gene: nidogen-2 is not essential for basement membrane formation in mice. Mol. Cell. Biol. 2002, 22:6820-6830.
30. Miosge N., Sasaki T., Timpl R. Evidence of nidogen-2 compensation for nidogen-1 deficiency in transgenic mice. Matrix Biol. 2002, 21:611-621.
31. Bader B.L., Smyth N., Nedbal S., Miosge N., Baranowsky A., Mokkapati S., Murshed M., Nischt R. Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice. Mol. Cell. Biol. 2005, 25:6846-6856.
32. Groffen A.J., Ruegg M.A., Dijkman H., van de Velden T.J., Buskens C.A., van den Born J., Assmann K.J., Monnens L.A., Veerkamp J.H., van den Heuvel L.P. Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J. Histochem. Cytochem. 1998, 46:19-27.
33. Burgess R.W., Nguyen Q.T., Son Y.J., Lichtman J.W., Sanes J.R. Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction. Neuron 1999, 23:33-44.
34. Burgess R.W., Skarnes W.C., Sanes J.R. Agrin isoforms with distinct amino termini: differential expression, localization, and function. J. Cell Biol. 2000, 151:41-52.
35. Ramseger R., White R., Kroger S. Transmembrane form agrin-induced process formation requires lipid rafts and the activation of Fyn and MAPK. J. Biol. Chem. 2009, 284:7697-7705.
36. Kanwar Y.S., Danesh F.R., Chugh S.S. Contribution of proteoglycans towards the integrated functions of renal glomerular capillaries. A historical perspective. Am. J. Pathol. 2007, 171:9-13.
37. Bohrer M.P., Baylis C., Humes H.D., Glassock R.J., Robertson C.R., Brenner B.M. Permselectivity of the glomerular capillary wall. Facilitated filtration of circulating polycations. J. Clin. Invest. 1978, 61:72-78.
38. Harvey S.J., Jarad G., Cunningham J., Rops A.L., van der Vlag J., Berden J.H., Moeller M.J., Holzman L.B., Burgess R.W., Miner J.H. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am. J. Pathol. 2007, 171:139-152.
39. Goldberg S., Harvey S.J., Cunningham J., Tryggvason K., Miner J.H. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane. Nephrol. Dial. Transplant. 2009, 24:2044-2051.
40. van den Hoven M.J., Wijnhoven T.J., Li J.P., Zcharia E., Dijkman H.B., Wismans R.G., Rops A.L., Lensen J.F., van den Heuvel L.P., van Kuppevelt T.H., Vlodavsky I., Berden J.H., van der Vlag J. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria. Kidney Int. 2008, 73:278-287.
41. Axelsson J., Sverrisson K., Rippe A., Fissell W., Rippe B. Reduced diffusion of charge modified, conformationally intact anionic Ficoll relative to neutral Ficoll across the rat glomerular filtration barrier in vivo. Am. J. Physiol. Renal Physiol. 2011, 301:F708-F712.
42. Haraldsson B., Nystrom J., Deen W.M. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 2008, 88:451-487.
43. Hausmann R., Kuppe C., Egger H., Schweda F., Knecht V., Elger M., Menzel S., Somers D., Braun G., Fuss A., Uhlig S., Kriz W., Tanner G., Floege J., Moeller M.J. Electrical forces determine glomerular permeability. J. Am. Soc. Nephrol. 2010, 21:2053-2058.